ロード中...
Targeting gastrointestinal stromal tumors: the role of regorafenib
Gastrointestinal stromal tumor (GIST) is a devastating disease in the metastatic setting, but its natural history has been dramatically altered by the development of small molecule tyrosine kinase inhibitors, most notably imatinib. Although patients with advanced GIST live much longer today than the...
保存先:
| 出版年: | Onco Targets Ther |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4881930/ https://ncbi.nlm.nih.gov/pubmed/27284251 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S104081 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|